FDA approves Botox to treat chronic migraines
Sunday, October 17, 2010 - 07:31
in Health & Medicine
NEW YORK (Reuters) - The Food and Drug Administration on Friday approved Allergan Inc's anti-wrinkle injection Botox to treat chronic migraines.